Select Publications
Journal articles
2008, 'Increased novelty-induced motor activity and reduced depression-like behavior in NPY Y4 receptor knockout mice', BMC Pharmacology, 8, http://dx.doi.org/10.1186/1471-2210-8-s1-a17
,2008, 'Influence of estrous cycle on explorative behaviour of wild-type and prodynorphin knockout mice', BMC Pharmacology, 8, http://dx.doi.org/10.1186/1471-2210-8-s1-a6
,2008, 'Long-term depression-like effect of a single immune challenge in neuropeptide Y Y2 and Y4 receptor knockout mice', BMC Pharmacology, 8, http://dx.doi.org/10.1186/1471-2210-8-s1-a39
,2008, 'Peptidergic influences on proliferation, migration, and placement of neural progenitors in the adult mouse forebrain', Proceedings of the National Academy of Sciences of the United States of America, 105, pp. 3610 - 3615, http://dx.doi.org/10.1073/pnas.0712303105
,2008, 'PYY transgenic mice are protected against diet-induced and genetic obesity', Neuropeptides, 42, pp. 19 - 30, http://dx.doi.org/10.1016/j.npep.2007.11.003
,2008, 'Reduced anxiety-like and depression-related behavior in neuropeptide YY4 receptor knockout mice', Genes Brain and Behavior, 7, pp. 532 - 542
,2008, 'Y1 receptors are critical for the proliferation of adult mouse precursor cells in the olfactory neuroepithelium', Journal of Neurochemistry, 105, pp. 641 - 652, http://dx.doi.org/10.1111/j.1471-4159.2007.05188.x
,2007, 'Y2, Y4 receptors and obesity', Expert Review of Endocrinology and Metabolism, 2, pp. 163 - 173, http://dx.doi.org/10.1586/17446651.2.2.163
,2007, 'Erratum: Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome (Nature Medicine (2007) 13, (803-811))', Nature Medicine, 13, pp. 1120, http://dx.doi.org/10.1038/nm0907-1120
,2007, 'Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome', Nature Medicine, 13, pp. 803 - 811, http://dx.doi.org/10.1038/nm1611
,2007, 'Anticonvulsant and neuroprotective actions of endogenous dynorphin', BMC Pharmacology, 7, http://dx.doi.org/10.1186/1471-2210-7-s2-a10
,2007, 'Behavioral profiling of NPY in aggression and neuropsychiatric diseases', Peptides, 28, pp. 326 - 333
,2007, 'Dynorphin knockout reduces fat mass and increases weight loss during fasting in mice', Molecular Endocrinology, 21, pp. 1722 - 1735
,2007, 'Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors', Brain, 130, pp. 1017 - 1028
,2007, 'Experiments to localize the site for the anxiogenic action of NPY mediated by Y2 receptors in the mouse brain', BMC Pharmacology, 7, http://dx.doi.org/10.1186/1471-2210-7-s2-a14
,2007, 'Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor-mediated pathways', Endocrinology, 148, pp. 2056 - 2065
,2007, 'Gastrointestinal hormones (anorexigenic peptide YY and orexigenic ghrelin) influence neural tube development', Federation of American Societies for Experimantal Biology Journal, 21, pp. 2108 - 2112
,2007, 'Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression', The Journal of Biological Chemistry, 282, pp. 19082 - 19091
,2007, 'Neuropeptide Y in the recurrent mossy fiber pathway', Peptides, 28, pp. 357 - 364
,2007, 'Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus', Neurobiology of Disease, 26, pp. 174 - 188
,2007, 'Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis', The Journal of Biological Chemistry, 282, pp. 19092 - 19102, http://dx.doi.org/10.1074/jbc.M700644200
,2007, 'NPY and receptors in immune and inflammatory diseases', Current Topics in Medicinal Chemistry, 7, pp. 1743 - 1752
,2007, 'The control of bone remodeling by neuropeptide Y receptors', Peptides, 28, pp. 320 - 325
,2007, 'The role of peptide YY in regulating glucose homeostasis', Peptides, 28, pp. 390 - 395
,2007, 'The Y-1 receptor for NPY: A key modulator of the adaptive immune system', Peptides, 28, pp. 453 - 458
,2007, 'Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1', Nature Medicine, 13, pp. 1333 - 1340
,2006, 'Erratum: Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice (Journal of Biological Chemistry (2006) 281, (23436-23444))', Journal of Biological Chemistry, 281, pp. 38966
,2006, 'The Central Control of Bone Remodeling', , pp. 361 - 376, http://dx.doi.org/10.1016/B978-012088562-6/50022-4
,2006, 'NPY and bone.', EXS, pp. 171 - 182, http://dx.doi.org/10.1007/3-7643-7417-9_13
,2006, 'Peptide YY: Lessons from mouse models', Current Opinion in Endocrinology and Diabetes, 13, pp. 65 - 69, http://dx.doi.org/10.1097/01.med.0000200524.26578.3b
,2006, 'Y2Y4 Receptor Double Knockout Protects Against Obesity Due to a High-Fat Diet or Y1 Receptor Deficiency in Mice', Diabetes, 55, pp. 19 - 26, http://dx.doi.org/10.2337/diabetes.55.01.06.db05-0472
,2006, 'Central control of cortical bone homeostasis: Neuropeptide Y exerts a negative effect on cortical bone formation', Bone, 38, pp. S6 - S6
,2006, 'Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals', Journal of Comparative Neurology, 499, pp. 357 - 390
,2006, 'Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity', Endocrinology, 147, pp. 5094 - 5101
,2006, 'Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice', The Journal of Biological Chemistry, 281, pp. 23436 - 23444, http://dx.doi.org/10.1074/jbc.M604839200
,2006, 'Critical role for peptide YY in protein-mediated satiation and body-weight regulation', Cell Metabolism, 4, pp. 223 - 233
,2006, 'Deletion of hypothalamic neuropeptide Y2-receptors in adult mice protects against continued ovariectomy-induced bone loss', Bone, 38, pp. S6 - S6
,2006, 'Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: Evidence from receptor knockout mice', Epilepsia, 47, pp. 773 - 780
,2006, 'Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats', Neuropharmacology, 51, pp. 1129 - 1136
,2006, 'Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain', Neuropeptides, 40, pp. 115 - 123
,2006, 'Effect of Y-1 receptor deficiency on motor activity, exploration, and anxiety', Behavioural Brain Research, 167, pp. 87 - 93
,2006, 'Emotional behavior in aged neuropeptide Y (NPY)Y-2 knockout mice', Journal of Molecular Neuroscience, 28, pp. 239 - 245
,2006, 'Hypothalamic neuropeptide Y exerts a negative effect on cortical bone formation', Journal of Bone and Mineral Research, 21, pp. S65 - S65
,2006, 'Hypothalamic regulation of cortical bone mass: Opposing activity of Y2 receptor and leptin pathways', Journal of Bone and Mineral Research, 21, pp. 1600 - 1607
,2006, 'Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes', Neuropeptides, 40, pp. 317 - 324
,2006, 'Neuropeptide Y (NPY) Y-4 receptor selective agonists based on NPY(32-36): Development of an anorectic Y-4 receptor selective agonist with picomolar affinity', Journal of Medicinal Chemistry, 49, pp. 2661 - 2665
,2006, 'Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: correlation with Y2 receptor plasticity', Neuroscience, 143, pp. 1085 - 1094
,2006, 'Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity', Diabetologia, 49, pp. 1360 - 1370
,2006, 'Selective increase of dark phase water intake in neuropeptide-Y Y2 and Y4 receptor knockout mice', Behavioural Brain Research, 168, pp. 255 - 260
,2006, 'The role of neuropeptide Y in the neuroproliferation of adult olfactory stem cells', CYTOMETRY PART A, 69A, pp. 407 - 408
,